Results 111 to 120 of about 5,463 (146)

Oral lichenoid lesions in association with immunotherapies: a report of two cases and a review of published work. [PDF]

BMC Oral Health
Huang F, Song Y, Wang X, Wang W, Duan N.
europepmc   +1 more source

Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN.

Blood
Sharman JP, Egyed M, Jurczak W, Skarbnik A, Patel K, Flinn IW, Kamdar M, Munir T, Walewska R, Hughes M, Fogliatto LM, Herishanu Y, Banerji V, Follows G, Walker P, Ghia P, Janssens A, Byrd JC, Ferrant E, Ferrajoli A, Wierda WG, Wachira CW, Suterwala BT, Miranda P, Munugalavadla V, Wun CC, Woyach JA.   +26 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Obinutuzumab

Reactions Weekly
  +17 more sources

Obinutuzumab

Reactions Weekly, 2021
  +6 more sources

Obinutuzumab

Reactions Weekly, 2022
  +6 more sources

Obinutuzumab

Reactions Weekly, 2019
  +5 more sources